Funded startups/Cerium Pharmaceuticals, Inc.

Cerium Pharmaceuticals, Inc.

SEC filing

Pharmaceuticals · Gaithersburg, MD

Form D on EDGAR

Amount raised$750Ksold at filing

Total offering$2.5M$1.8M still open

Investors in the raise4count reported to the SEC

FiledAug 6, 2026first sale May 22, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Steve A. EskenaziDirector

Peter A. CollumDirector

James A. GaleDirector

Tom A. DePasqualeDirector

Gregg A. LapointeExecutive Officer, Director

Robert A. RubinDirector

Executive officers, directors and promoters as listed on the Form D.